Emergency
Opioid overdose — the essentials
Opioid overdose is opioid-induced respiratory depression — an airway/breathing emergency before it is a "drug" emergency. The single threat to life is hypoventilation leading to hypoxia, then respiratory and cardiac arrest. The nursing priority is to recognize the toxidrome (CNS depression + respiratory depression + pinpoint pupils), support oxygenation and ventilation, and give naloxone per protocol titrated to adequate spontaneous respiration — not to full wakefulness.
Recognize it (red flags)
- The classic triad: pinpoint pupils + decreased level of consciousness + slow, shallow breathing after suspected opioid exposure
- Marked bradypnea (often RR <12/min, severe at <=8/min) or agonal/apneic breathing — this is the key driver
- Cyanosis of lips/fingertips; snoring, gurgling, or choking airway sounds from soft-tissue obstruction
- Re-sedation: breathing or LOC deteriorating again after an initial response means naloxone has been outlasted by the opioid
- Unresponsive with no normal breathing and no pulse = start CPR and call a code; if a pulse is present but breathing is inadequate, ventilate and give naloxone — do not start compressions
Key numbers
- Naloxone (IV/IM/SC)
- 0.4 mg, repeat every 2-3 min per protocol
- Naloxone (intranasal)
- 4 mg/0.1 mL, alternate nostrils
- Low-dose IV titration
- 0.04-0.1 mg in known opioid-dependent patients (per protocol)
- Naloxone duration of action
- ~30-90 min (shorter than many opioids)
- Reassessment endpoint
- RR rising toward >=10-12/min, improving SpO2 and LOC
- No response after total
- ~10 mg naloxone → reconsider diagnosis, escalate
- Observation (long-acting opioid)
- ~6-12 h for re-sedation (verify per guideline)
Priority nursing actions
- Open and support the airway first: head-tilt/chin-lift or jaw-thrust, suction, and bag-mask ventilation with 100% O2 for RR <8 or apnea when a pulse is present
- Give naloxone PER ORDER/protocol, titrating to adequate spontaneous respiration (RR ~10-12/min), not to full arousal — choose route by access (IV fastest)
- Apply the rights of medication administration even under time pressure, and reassess RR, SpO2, and LOC after every dose
- Repeat naloxone every 2-3 minutes if breathing/LOC is not improving; activate rapid response or a code as needed
- Keep the patient under observation for re-sedation, position to prevent aspiration, and arrange take-home naloxone and MOUD linkage before discharge
Common NGN / NCLEX traps
- Waiting for naloxone to "work" instead of ventilating — ventilation is the priority intervention
- Pushing a large naloxone bolus for full arousal in a chronic user — risks severe precipitated withdrawal, vomiting, and aspiration
- Discharging or leaving the patient after one dose — re-sedation is the lethal trap because naloxone is shorter-acting than many opioids
- Treating the SpO2 number rather than ventilation, or assuming normal pupils rule out opioids when a co-ingestant is present
- Starting chest compressions on a patient who has a pulse — ventilate and give naloxone instead
For practicing nurses
What’s changed (if you trained a while ago)
- Illicit synthetic opioids (fentanyl) and polysubstance (opioid + stimulant) exposures now dominate overdoses, and counterfeit pills are common (CDC).
- The teaching point is naloxone’s duration of action (~30-90 min), not its half-life — that mismatch is what makes re-sedation possible.
- Guidance is "give naloxone and call 911 — do not wait and see"; titrate to ventilation, not full arousal, especially in dependent patients.
- Harm reduction is now part of the RN role: provide take-home naloxone, teach against opioid + alcohol/benzodiazepine combinations, and arrange rapid linkage to medication for opioid use disorder (MOUD).
On the floor (practical pearls)
- Ventilate before and with naloxone — do not withhold bag-mask ventilation while waiting for the drug to take effect.
- Titrate to breathing, not to a fully awake patient: the endpoint is adequate spontaneous respiration (RR ~10-12/min and rising SpO2), which limits precipitated withdrawal.
- Plan for re-sedation: long-acting or sustained-release opioids (methadone, ER oxycodone, transdermal fentanyl) warrant prolonged observation and may need repeat dosing.
- Hold any scheduled opioid and sedating co-meds (benzodiazepines) and notify the prescriber if RR <=12/min or the patient is excessively sedated.
- Naloxone is high-alert for dose accuracy and abrupt behavioral escalation, but it is NOT a vesicant — no extravasation antidote is needed; standard IV-site monitoring is enough.
- If there is no response after ~10 mg total naloxone, reconsider a non-opioid or mixed cause and pursue toxicology/prescriber escalation — that decision is prescriber-directed, not RN-initiated dosing.
Key references
- 2023 Focused Update on Cardiac Arrest / Toxicity Due to Poisoning, Circulation (AHA), 2023
- Naloxone — StatPearls, NCBI Bookshelf, 2024
- Opioid Toxicity — StatPearls, NCBI Bookshelf, 2024
- Davis's Drug Guide for Nurses — Naloxone monograph, F.A. Davis, 2024
- Lewis's / Brunner & Suddarth's Medical-Surgical Nursing — poisoning emergencies, 2023
Sources: Based on the 2023 AHA Toxicology Focused Update, the WHO 2024 Opioid Overdose Fact Sheet, BMJ Best Practice (2024), CDC, and StatPearls (Naloxone / Opioid Toxicity, 2024).
